Reversibility of the monocrotaline pulmonary hypertension rat model

Eur Respir J. 2013 Aug;42(2):553-6. doi: 10.1183/09031936.00012313.
No abstract available

Publication types

  • Letter

MeSH terms

  • Animals
  • Arterioles / drug effects
  • Disease Models, Animal
  • Disease Progression
  • Drug Administration Schedule
  • Echocardiography
  • Hemodynamics
  • Hypertension, Pulmonary / chemically induced
  • Hypertension, Pulmonary / physiopathology*
  • Hypertension, Pulmonary / therapy*
  • Liver / drug effects
  • Male
  • Monocrotaline / adverse effects*
  • Pulmonary Artery / drug effects
  • Random Allocation
  • Rats
  • Rats, Wistar

Substances

  • Monocrotaline